on July 15, 2026
Quick answer
Milk thistle is the plant. Silymarin is the group of active compounds extracted from its seeds. The two terms are often used interchangeably, but they are not the same thing. What your liver actually uses is silymarin, specifically silybin, and how well it reaches the liver depends almost entirely on the delivery form, not the dose on the label.
If you have looked into liver health supplements, you have probably encountered both terms. Milk thistle. Silymarin. They appear on the same products, sometimes interchangeably. Understanding the distinction, and why it matters for the supplement you choose, is the subject of this article.
Milk Thistle vs Silymarin: The Core Difference
Milk thistle (Silybum marianum) is a flowering plant in the daisy family, native to the Mediterranean and now cultivated worldwide. The seeds of the plant are where the active compounds are concentrated.
Silymarin is the standardised complex of active compounds extracted from those seeds. It comprises four flavonolignans: silybin (the most biologically active), isosilybin, silychristin, and silydianin. When a supplement is labelled as milk thistle extract, the relevant measure of potency is the silymarin percentage, typically between 70 and 80 percent in a standardised extract.
When you take a milk thistle supplement, what does the biological work in your liver is silymarin, and more specifically, silybin. Not the plant itself.
Three terms you will see on labels
- Milk thistle: The plant (Silybum marianum). Broad term that tells you the botanical source.
- Milk thistle extract: The concentrated extract from the seeds. Potency varies significantly depending on silymarin content.
- Silymarin: The standardised active fraction. A percentage (e.g. 70% silymarin) tells you how much of the biologically active compound the extract contains.
What Silymarin Does for the Liver
Silymarin is one of the most extensively studied plant-derived compounds for liver health. Research has identified seven documented mechanisms of action:
- Antioxidant: Activates glutathione and superoxide dismutase (SOD) enzyme systems that neutralise reactive oxygen species in liver cells.
- Anti-inflammatory: Inhibits NF-κB, JNK, and MAPK signalling pathways that drive liver inflammation.
- Membrane protection: Maintains hepatocyte cell membrane integrity, reducing permeability and enzyme leakage.
- Anti-fibrotic: Inhibits hepatic stellate cell activation, the primary driver of scar tissue formation in the liver.
- Liver cell regeneration: Supports hepatocyte protein synthesis and cell repair.
- Immunomodulatory: Activates the Nrf2 pathway, which regulates the body's antioxidant response.
- Anti-lipid peroxidative: Reduces oxidation of fats within liver cells, protecting against fat-driven cell damage.
Silymarin has been formally studied in NAFLD (non-alcoholic fatty liver disease), alcoholic liver disease, drug-induced liver injury (DILI), and fibrosis. A meta-analysis of 8 randomised controlled trials (Zhong S et al., 2017) confirmed silymarin significantly reduces ALT and AST in NAFLD patients. A systematic review of 5 RCTs (Saller R et al., 2001) demonstrated a 57.8% reduction in liver-related mortality with silymarin versus placebo in alcoholic liver disease and cirrhosis.
The Absorption Problem: Why Standard Milk Thistle Tablets Often Fall Short
Here is the part that most supplement labels do not tell you.
Silymarin is poorly water-soluble and has low intestinal permeability. In standard tablet or capsule form, fewer than 50 percent of an oral dose makes it into the bloodstream. The rest passes through the gut without being absorbed.
This is not a new finding. It has been documented consistently across pharmacokinetic studies. The practical consequence: a 500 mg milk thistle tablet delivering 70% silymarin (350 mg silymarin) may result in less than 175 mg reaching systemic circulation, and far less reaching the liver.
Clinical Bioavailability Data
9.6× higher
Liposomal silybin (phospholipid-bound) achieves peak plasma concentrations 9.6 times higher than conventional silymarin tablets in head-to-head pharmacokinetic comparison. The liver's scavenger receptors actively bind and absorb phospholipid vesicles below 300 nm, enabling significantly greater hepatic delivery.
Nahum V et al. (2019). BMC Pharmacology and Toxicology.
Liposomal Silymarin: What Changes with Phospholipid Delivery
Liposomal delivery encases silymarin in phospholipid vesicles, typically below 300 nm in size. Phospholipids are the same structural material that makes up the liver's own cell membranes. The liver has scavenger receptors that actively bind and internalise these vesicles, enabling significantly greater hepatic delivery than a standard tablet allows.
The result, documented by Nahum V et al. (2019), is 9.6 times higher peak plasma concentration of silybin with phospholipid-bound delivery compared to conventional tablets.
What to look for on a silymarin supplement label
- Standardised silymarin percentage (70–80% is typical for quality extracts)
- Delivery format clearly stated: liposomal, phospholipid complex, or phytosome
- Encapsulation efficiency if liposomal (85%+ is well-characterised)
- Vesicle size below 300 nm for effective hepatic absorption
- Third-party testing and manufacturing certifications (EU-GMP, ISO 22000, FSSAI)
Is Silymarin Safe for Daily Use?
Silymarin is well-tolerated clinically. No serious adverse effects have been documented at therapeutic doses in clinical trials. Mild gastrointestinal effects (loose stools, nausea) are the most commonly reported, and typically resolve with continued use or dose adjustment.
If you are on long-term prescription medication, particularly statins, antifungals, or immunosuppressants, consult your doctor before starting, as silymarin may influence how certain hepatic enzymes (CYP3A4, CYP2C9) process drugs. This interaction potential is theoretical at standard doses but worth discussing with a prescribing doctor.
Frequently Asked Questions
What is the difference between milk thistle and silymarin?
Milk thistle is the plant (Silybum marianum). Silymarin is the group of active compounds extracted from its seeds. When you take a milk thistle supplement, silymarin is what does the work, specifically its most active constituent, silybin. Not all milk thistle supplements deliver the same amount of silymarin, and not all silymarin is equally absorbed.
Is silymarin the same as milk thistle extract?
Silymarin is the standardised active fraction of milk thistle extract. Milk thistle extract is the broader term; silymarin is the specific compound complex, four flavonolignans, that gives the extract its liver-protective properties. Quality supplements will specify the silymarin percentage, not just milk thistle extract.
Does silymarin actually reach the liver when taken as a tablet?
In standard tablet form, fewer than 50 percent of an oral dose makes it into the bloodstream, because silymarin has poor water solubility and low intestinal permeability. Liposomal delivery addresses this by encasing silymarin in phospholipid vesicles below 300 nm, which the liver's own scavenger receptors actively bind and absorb. Clinical data shows 9.6 times higher bioavailability with phospholipid-bound silybin compared to standard tablets.
What does silymarin do for the liver?
Research has identified seven mechanisms: antioxidant action (activates glutathione and SOD enzyme systems), anti-inflammatory (inhibits NF-κB and cytokine signalling), membrane protection (maintains hepatocyte cell membrane integrity), anti-fibrotic (inhibits scar tissue formation), liver cell regeneration (supports hepatocyte protein synthesis), immunomodulatory (activates Nrf2 pathway), and anti-lipid peroxidative (reduces fat oxidation in liver cells). It has been formally studied in NAFLD, alcoholic liver disease, drug-induced liver injury, and fibrosis.
How long does it take for silymarin to show results in liver enzyme levels?
Clinical studies typically measure outcomes at 8 to 24 weeks of consistent daily use. Meaningful reductions in ALT and AST have been observed in NAFLD patients within 8 to 12 weeks when silymarin is taken at therapeutic doses. The timeline depends significantly on the underlying cause of enzyme elevation, the dose, and critically, the delivery form. Liposomal silymarin, which achieves substantially higher bioavailability than standard tablets, is more likely to produce measurable results within this window. Liver enzyme testing at baseline and again at 12 weeks is a practical way to assess response.
Meru Activs · Designed for Life After 50
Phospholipids Liver Essentials
India's first liposomal silymarin formulation built specifically for adults 50 and above. LECIVA-SilyLip technology. 85% verified encapsulation efficiency. 9.6x bioavailability vs standard tablets. 100% vegetarian. FSSAI approved.
Learn MoreReferences
- Nahum V et al. (2019). Bioavailability of silybin-phosphatidylcholine complex vs conventional silymarin tablets. BMC Pharmacology and Toxicology.
- Zhong S et al. (2017). Silymarin in NAFLD: meta-analysis of 8 randomised controlled trials.
- Gillessen A et al. (2020). Silymarin for treating toxic liver disease: consensus panel.
- Saller R et al. (2001). Silymarin in alcoholic liver disease and cirrhosis. Drugs 61(14):2035–2063.
- Pradhan SC & Girish C (2006). Hepatoprotective herbal drug, silymarin. Indian J Med Res 124:491–504.
Disclaimer: This article is for educational and informational purposes only. It is not intended to diagnose, treat, cure, or prevent any disease or medical condition. Consult a qualified healthcare professional before starting any supplement, particularly if you take prescription medication. Meru Activs Phospholipids Liver Essentials is an FSSAI-approved nutraceutical.